Our research provided instrument manufacturers such as Kratos, Thermo, ION-TOF, PHI and Ionoptika with the direction and confidence to develop argon cluster ion sources, which needed significant R&D investment. Kratos, Thermo and ION-TOF have sold over 200 of these ion guns with commercial values between £150-250k each. This level of consumer confidence in a technology only a few years old is directly attributable to the work carried out at NPL.
On top of this, GlaxoSmithKline have invested more than £300k to use 3D SIMS to study drug disposition in cells and tissue at high spatial resolution and made a substantial co-investment in a project led by NPL to build a revolutionary new instrument, the 3D nanoSIMS. ION-TOF and Thermo Scientific are building this new instrument, which will become a new product.
“…The pioneering research at NPL showed unequivocally that argon clusters are superior. Following this research and the invited talk by (Dr Ian) Gilmore at SIMS Europe 2010, ION-TOF focused on the rapid development of an argon cluster ion beam. This has been an outstandingly successful product selling over 80 units with values of around €200k each. This is obviously commercially important to ION-TOF but on the wider economic scale has enabled the many industry sectors we serve automotive, speciality chemicals, organic electronics, pharmaceuticals, coatings, agrochemicals entirely new insights into their product innovation”.
Dr Ewald Niehuis, Managing Director of ION-TOF
Find out more about NPL's Surface technology research